Stability and sterility of a recombinant factor VIII concentrate (Bioclate(TM)) prepared for continuous infusion prophylaxis

被引：0
|
作者：
Belgaumi, AF
Patrick, CC
Tonkel, S
Deitcher, SR
Jude, S
机构：
[1] CHILDRENS RES HOSP, MEMPHIS, TN USA
[2] UNIV TENNESSEE, MEMPHIS, TN USA
来源：
THROMBOSIS AND HAEMOSTASIS | 1997年
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：P2092 / P2092
页数：1
相关论文
共 50 条
  • [1] Stability and sterility of a recombinant factor VIII concentrate prepared for continuous infusion administration
    Belgaumi, AF
    Patrick, CC
    Deitcher, SR
    AMERICAN JOURNAL OF HEMATOLOGY, 1999, 62 (01) : 13 - 18
  • [2] Stability and sterility of sucrose-formulated recombinant factor VIII (Kogenate® FS/Bayer) during continuous infusion
    Regan, L.
    Chew, J.
    Vo, K.
    Leveque, J.
    Khabbaz, N.
    Gorina, E.
    HAEMOPHILIA, 2008, 14 : 13 - 14
  • [3] Stability and sterility of sucrose-formulated recombinant factor VIII (Kogenate® FS/Bayer) for use during continuous infusion.
    Regan, Lisa
    Chew, Jordan
    Vo, Khang
    Leveque, Joyce
    Khabbaz, Naji
    Gorina, Eduard
    BLOOD, 2006, 108 (11) : 79B - 79B
  • [4] Stability and sterility of dilute solutions of monoclonal antibody purified factor IX (Mononine(R)) concentrate prepared for continuous infusion.
    Rood, GS
    Thill, W
    Flanigan, E
    BLOOD, 1995, 86 (10) : 3530 - 3530
  • [5] Evaluation of recombinant factor VIII (Kogenate®) stability for continuous infusion using a minipump infusion device
    Hurst, D
    Zabor, S
    Malianni, D
    Miller, D
    HAEMOPHILIA, 1998, 4 (06) : 785 - 789
  • [6] Stability of turoctocog alfa, a recombinant factor VIII product, during continuous infusion in vitro
    Kawasugi, K.
    Pollard, D.
    Nohr, A. M.
    Rasmussen, D. K. Normann
    Jensen, J. Taaftegaard
    Takeyama, M.
    HAEMOPHILIA, 2019, 25 : 48 - 48
  • [7] In vitro and in vivo stability of diluted recombinant factor VIII for continuous infusion use in haemophilia A
    Revel-Vilk, S.
    Blanchette, V. S.
    Schmugge, M.
    Clark, D. S.
    Lillicrap, D.
    Rand, M. L.
    HAEMOPHILIA, 2010, 16 (01) : 72 - 79
  • [8] Recombinant factor IX (BeneFix®) by adjusted continuous infusion:: a study of stability, sterility and clinical experience
    Chowdary, P
    Dasani, H
    Jones, JAH
    Loran, CM
    Eldridge, A
    Hughes, S
    Collins, PW
    HAEMOPHILIA, 2001, 7 (02) : 140 - 145
  • [9] CONTINUOUS INFUSION THERAPY OF FACTOR-VIII CONCENTRATE IN HEMOPHILIA-A
    LEVIN, J
    NESS, PM
    BELL, WR
    TRANSFUSION, 1981, 21 (05) : 621 - 622
  • [10] Preliminary evaluation of factor VIII/vWF concentrate (FANHDI(R)) for continuous infusion: Stability and bacteriological safety
    Martinowitz, U
    Schulman, S
    Gitel, S
    Keller, N
    Lubetzky, A
    Varon, D
    THROMBOSIS AND HAEMOSTASIS, 1997, : PS228 - PS228
12345